Profound Medical (PROF) Competitors $7.35 +0.08 (+1.10%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PROF vs. IRMD, KIDS, AXGN, SIBN, FNA, ZIMV, BFLY, CLPT, TCMD, and NNOXShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include Iradimed (IRMD), OrthoPediatrics (KIDS), AxoGen (AXGN), SI-BONE (SIBN), Paragon 28 (FNA), ZimVie (ZIMV), Butterfly Network (BFLY), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Profound Medical vs. Iradimed OrthoPediatrics AxoGen SI-BONE Paragon 28 ZimVie Butterfly Network ClearPoint Neuro Tactile Systems Technology Nano-X Imaging Profound Medical (NASDAQ:PROF) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment. Do insiders and institutionals hold more shares of PROF or IRMD? 47.9% of Profound Medical shares are held by institutional investors. Comparatively, 92.3% of Iradimed shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 37.1% of Iradimed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor PROF or IRMD? In the previous week, Iradimed had 11 more articles in the media than Profound Medical. MarketBeat recorded 13 mentions for Iradimed and 2 mentions for Profound Medical. Iradimed's average media sentiment score of 0.54 beat Profound Medical's score of 0.00 indicating that Iradimed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Iradimed 1 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, PROF or IRMD? Profound Medical has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Which has preferable valuation and earnings, PROF or IRMD? Iradimed has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$7.20M25.17-$28.57M-$1.22-6.02Iradimed$69.48M8.81$17.19M$1.4633.08 Is PROF or IRMD more profitable? Iradimed has a net margin of 26.83% compared to Profound Medical's net margin of -350.14%. Iradimed's return on equity of 24.71% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-350.14% -71.28% -54.70% Iradimed 26.83%24.71%20.86% Do analysts prefer PROF or IRMD? Profound Medical currently has a consensus target price of $13.75, indicating a potential upside of 87.07%. Iradimed has a consensus target price of $60.00, indicating a potential upside of 24.22%. Given Profound Medical's higher possible upside, equities research analysts plainly believe Profound Medical is more favorable than Iradimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Iradimed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor PROF or IRMD? Iradimed received 213 more outperform votes than Profound Medical when rated by MarketBeat users. However, 72.22% of users gave Profound Medical an outperform vote while only 64.78% of users gave Iradimed an outperform vote. CompanyUnderperformOutperformProfound MedicalOutperform Votes3972.22% Underperform Votes1527.78% IradimedOutperform Votes25264.78% Underperform Votes13735.22% SummaryIradimed beats Profound Medical on 12 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$181.25M$4.41B$5.40B$8.53BDividend YieldN/A42.37%5.13%4.14%P/E Ratio-6.0238.74115.5615.18Price / Sales25.1765.071,484.3492.77Price / CashN/A49.1039.6634.07Price / Book5.744.264.665.02Net Income-$28.57M$11.52M$119.06M$225.46M7 Day Performance0.55%1.04%0.80%0.37%1 Month Performance-9.93%0.92%5.65%3.57%1 Year Performance-19.76%39.40%36.76%29.44% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical2.1805 of 5 stars$7.35+1.1%$13.75+87.1%-13.3%$181.25M$7.20M-6.02150Upcoming EarningsNews CoverageIRMDIradimed4.8625 of 5 stars$50.77+0.8%$60.00+18.2%+17.6%$643.26M$65.56M34.77110Dividend AnnouncementNews CoverageKIDSOrthoPediatrics4.0912 of 5 stars$26.43+2.9%$40.00+51.3%+11.1%$639.87M$148.73M-24.25200Upcoming EarningsAXGNAxoGen1.0824 of 5 stars$13.69+2.9%$15.00+9.6%+286.4%$598.32M$173.48M-36.03426Upcoming EarningsSIBNSI-BONE4.214 of 5 stars$13.02+2.8%$22.67+74.1%-21.8%$542.80M$138.89M-12.89350FNAParagon 282.4163 of 5 stars$5.13+4.9%$15.25+197.3%-38.0%$428.56M$216.39M-7.43343,000Gap UpZIMVZimVie2.4593 of 5 stars$14.08+1.5%$18.33+30.2%+108.6%$388.19M$457.43M-1.072,600News CoverageBFLYButterfly Network2.4107 of 5 stars$1.83+0.5%$3.00+63.9%+151.5%$385.60M$71.08M-3.59460Earnings ReportNews CoverageGap UpCLPTClearPoint Neuro0.9281 of 5 stars$13.33+2.2%$11.33-15.0%+126.9%$365.51M$28.07M-18.77110Upcoming EarningsShort Interest ↑News CoverageTCMDTactile Systems Technology2.5741 of 5 stars$14.54+2.4%$23.00+58.2%+25.4%$345.47M$274.42M10.54980Upcoming EarningsNNOXNano-X Imaging1.1351 of 5 stars$5.93+2.6%$14.00+136.1%+13.8%$342.63M$10.13M-5.99190News CoveragePositive News Related Companies and Tools Related Companies IRMD Competitors KIDS Competitors AXGN Competitors SIBN Competitors FNA Competitors ZIMV Competitors BFLY Competitors CLPT Competitors TCMD Competitors NNOX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PROF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
